Implantable Cardioverter Defibrillator Market, By Product Type (Implantable Cardioverter Defibrillator (Transvenous ICD, Subcutaneous ICD), External Cardioverter Defibrillator ( Manual External Defibrillator, Automated External Defibrillator, Wearable External Defibrillator )), End User (Hospitals & Clinics, Ambulatory Surgery Centers and Others) and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2032

Report Code: PMI500822 | Publish Date: December 2022 | No. of Pages: 170

Implantable Cardioverter Defibrillator Market Overview

An implantable cardioverter-defibrillator (ICD) is a small battery-operated device placed in the chest to detect and stop irregular heartbeats. An implantable cardioverter defibrillator continuously monitors the heartbeat and delivers an electric shock as needed to restore a regular heart rhythm. ICD is a type of cardiac therapy device, ICD is divided into two types such as conventional ICD and subcutaneous ICD, conventional implantable cardioverter defibrillator is implanted in the chest and the wires are connected to the heart, the implant procedure requires invasive surgery. Another option is a subcutaneous ICD that is implanted under the skin on the side of the chest under the armpit, attached to electrodes that run along the breastbone, and an S-ICD is larger than a traditional ICD but not connected to the heart. . An ICD continuously monitors for irregular heartbeats and attempts to correct them immediately, helping when the heart effectively stops beating (cardiac arrest). ICDs are useful in preventing sudden death in people who are at high risk of life-threatening arrhythmias, including ventricular tachycardia or ventricular fibrillation.Most ICDs, called transvenous ICDs, have a dual function, acting as a pacemaker. An implantable cardioverter defibrillator or automated implantable cardioverter defibrillator is an implantable device in the body, capable of defibrillation and depending on the heart type, cardioversion and speed. ICDs are first-line treatment and prophylactic therapy for patients at risk of sudden cardiac death without treatment. Pacemakers are often used when your heart beats too slowly, and an ICD is recommended if you are at risk for fatal ventricular arrhythmias. Your health care provider may have other reasons for recommending placement of a pacemaker or ICD. Low risk of Li poisoning in advanced ICDs of redvCID, high reliance of following ICDs is expected during the forecasted environment in the implantable cardioverter defibrillator market.

Attributes

Details

Implantable Cardioverter Defibrillator Market Value (2022)

US$ 10.3 Bn

Implantable Cardioverter Defibrillator Market Projected  Value(2032)

US$ 13.6 Bn

Implantable Cardioverter Defibrillator Market CAGR (2022-2032)

3.8%

Implantable Cardioverter Defibrillator Market Dynamics

Increasing number of patients suffering from cardiac disorders such as heart attack, abnormal heart rhythm, increasing demand for ICDs in the market and increase in cardiovascular diseases, increasing prevalence of cardiovascular diseases, increasing geriatric population, increasing applicability of implantable cardioverter defibrillators are the reasons driving the market growth. However, risks associated with post-surgical implantable cardioverter defibrillators may restrain the market growth to some extent. Restraints hindering the market growth are rising cost of ICD device and lack of awareness about implementation of ICD. Threats of device malfunction and lifestyle constraints are likely to hamper the market growth.

Technological advancement

The growth of the implantable defibrillators market is attributed to technological advances such as the introduction of quadripolar lead devices to improve device programming, increased battery life, and the development of magnetic resonance imaging-safe ICDs. In addition, ongoing technological advancements and addition of smart features in patient monitoring programs and surgical procedures will increase the market revenue during the forecast period. Recent advances in ICD technology include the development of quadripolar lead devices to improve therapy efficacy, extend battery life, and provide new pacing functions. Manufacturers involved in the Implantable Cardioverter Defibrillator market are developing advanced versions of their products due to new age technological advancements. Key players of Implantable Cardioverter Defibrillators are investing more in power systems and creating more modern, time-saving, cost-effective technologies that are positively impacting the Implantable Cardioverter Defibrillators market. In December 2022, the rhythmic sound of the heart beating is what cardiologists want to hear. Yet, for many heart patients, the path to that stable rhythm is not steady. It is rife with many iterative technological innovations based on scientific technology and exciting medical disruptions.

Access Crucial Insights at a Fraction of the Cost | Request Your Discount

Implantable Cardioverter Defibrillator Market Segmentation

Disclaimer: This data is only a representation. Actual data may vary and will be available in the report.

The Implantable Cardioverter Defibrillator Market is segmented based on product type, end user, and region.

On the basis of product type, the Implantable Cardioverter Defibrillator Market is segmented into Implantable Cardioverter Defibrillator (Transvenous ICD, Subcutaneous ICD), External Cardioverter Defibrillator ( Manual External Defibrillator, Automated External Defibrillator, Wearable External Defibrillator ). On the basis of end user, the target market is classified into Hospitals & Clinics, Ambulatory Surgery Centers and Others.

Regional Insights:

Disclaimer: This data is only a representation. Actual data may vary and will be available in the report.

On region the Implantable Cardioverter Defibrillator Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is expected to be the largest implantable cardioverter defibrillator market during the forecast period, owing to increasing prevalence of heart disease, high adoption rate of cardiac implantable electronic devices, presence of a well-established healthcare sector, and the US being the largest growing region due to growing elderly population in the region.

Reduce costs by up to 30% with a custom report tailored to your specific needs | Request Customized Report

Report Scope:                                      

Attribute

Details

Base year for estimation

2022

Forecast period

2022 – 2032

Market representation

Revenue in USD Billion & CAGR from 2022 to 2032

Market Segmentation

By Product Type - Implantable Cardioverter Defibrillator (Transvenous ICD, Subcutaneous ICD), External Cardioverter Defibrillator ( Manual External Defibrillator, Automated External Defibrillator, Wearable External Defibrillator )

End User - Hospitals & Clinics, Ambulatory Surgery Centers and Others

Regional scope

North America - U.S., Canada

Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe

Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific

Latin America - Brazil, Mexico, Argentina, Rest of Latin America

Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa

Report coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments Covered in the Report:

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2022 to 2032. For the purpose of this study, has segmented the Implantable Cardioverter Defibrillator Market report based on product type, end user and region:

Implantable Cardioverter Defibrillator Market, By Product Type:

  • Implantable Cardioverter Defibrillator (Transvenous ICD, Subcutaneous ICD)
  • External Cardioverter Defibrillator ( Manual External Defibrillator, Automated External Defibrillator, Wearable External Defibrillator )

Implantable Cardioverter Defibrillator Market, By End User:

  • Hospitals & Clinics
  • Ambulatory Surgery Centers
  • Others

Implantable Cardioverter Defibrillator Market, By Region:

      • North America
          • U.S.
          • Canada
      • Europe
          • Germany
          • UK
          • France
          • Russia
          • Italy
          • Rest of Europe
      • Asia Pacific
          • China
          • India
          • Japan
          • South Korea
          • Rest of Asia Pacific
      • Latin America
          • Brazil
          • Mexico
          • Rest of Latin America
      • Middle East & Africa
          • GCC
          • Israel
          • South Africa
          • Rest of Middle East & Africa

Implantable Cardioverter Defibrillator Market Key Players

The key players operating the Implantable Cardioverter Defibrillator Market includes, Medtronic, Boston Scientific Corporation, Biotronik, LivaNova Plc, Abbott, Microport, Koninklijke Philips N.V., Nihon Kohden Corporation, Progetti Srl, Fukuda Denshi Co., Ltd, Getinge, ZOLL Medical Corporation.

Recent Developments:

  • In December 2021, Boston Scientific initiated a trial to evaluate the safety and efficacy of the mCRM Modular Therapy System. The Mcrm system consists of two cardiac rhythm management devices: the EMBLEM MRI Subcutaneous Implantable Defibrillator System and the Empower Modular Pacing System.

Implantable Cardioverter Defibrillator Market Company Profile

  • Medtronic*
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Boston Scientific Corporation
  • Biotronik
  • LivaNova Plc
  • Abbott
  • Microport
  • Koninklijke Philips N.V.
  • Nihon Kohden Corporation
  • Progetti Srl
  • Fukuda Denshi Co., Ltd
  • Getinge
  • ZOLL Medical Corporation

 “*” marked represents similar segmentation in other categories in the respective section

Implantable Cardioverter Defibrillator Market Table of Contents

  1. Research Objective and Assumption
    • Preface
    • Research Objectives
    • Study Scope
    • Years Considered for the study
    • Assumptions
    • Abbreviations
  2. Research Methodology
    • Research data
    • Primary Data
      • Primary Interviews
      • Primary Breakdown
      • Key data from Primary End Users
      • Key Thickness Insights
    • Secondary Data
      • Major Secondary End Users
      • Secondary End Users
    • Market Estimation
    • Top-Down Approach
      • Approach for estimating Market Share by Top-Down Analysis (Supply Side)
    • Bottom-Up Approach
      • Approach for estimating market share by Bottom-up Analysis (Demand Side)
    • Market Breakdown and Data Triangulation
    • Research Assumptions
  3. Market Purview
    • Executive Summary
    • Key Findings—Global Outlook for medical carts Strategies
      • Key Questions this Study will Answer
      • Market Snippet, By Product Type
      • Market Snippet, By End User
      • Market Snippet, By Region
    • Opportunity Map Analysis
    • Executive Summary—3 Big Predictions
  4. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
      • Market Trends
    • DR Impact Analysis
    • PEST Analysis
    • Porter’s Five Forces Analysis
    • Opportunity Orbit
    • Market Investment Feasibility Index
    • Macroeconomic Factor Analysis
  5. Implantable Cardioverter Defibrillator Market, By Product Type
    • Overview
      • Market Value and Forecast (US$ Bn), and Share Analysis (%), 2022 – 2032
      • Y-o-Y Growth Analysis (%), 2022 – 2032
      • Segment Trends
    • Implantable Cardioverter Defibrillator (Transvenous ICD, Subcutaneous ICD)
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
    • External Cardioverter Defibrillator ( Manual External Defibrillator, Automated External Defibrillator, Wearable External Defibrillator )
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
  6. Implantable Cardioverter Defibrillator Market, By End User
    • Overview
      • Market Value and Forecast (US$ Bn), and Share Analysis (%), 2022 – 2032
      • Y-o-Y Growth Analysis (%), 2022 – 2032
      • Segment Trends
    • Hospital & Clinics
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
    • Ambulatory Surgery Centers
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
    • Others
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
  7. Implantable Cardioverter Defibrillator Market, By Region, 2022 – 2032, (US$ Bn)
    • Overview
      • Market Value and Forecast (US$ Bn), and Share Analysis (%), 2022 – 2032
      • Y-o-Y Growth Analysis (%), 2022 – 2032
      • Regional Trends
    • North America
      • Market Size and Forecast (US$ Bn), By Product Type, 2022 – 2032
      • Market Size and Forecast (US$ Bn), By End User, 2022 – 2032
      • Market Size and Forecast (US$ Bn), By Country, 2022 – 2032
        • U.S.
        • Canada
    • Europe
      • Market Size and Forecast (US$ Bn), By Product Type, 2022 – 2032
      • Market Size and Forecast (US$ Bn), By End User, 2022 – 2032
      • Market Size and Forecast (US$ Bn), By Country, 2022 – 2032
        • UK
        • France
        • Germany
        • Russia
        • Italy
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast (US$ Bn), By Product Type, 2022 – 2032
      • Market Size and Forecast (US$ Bn), By End User, 2022 – 2032
      • Market Size and Forecast (US$ Bn), By Country, 2022 – 2032
        • India
        • Japan
        • South Korea
        • China
        • Rest of Asia Pacific
    • Latin America
      • Market Size and Forecast (US$ Bn), By Product Type, 2022 – 2032
      • Market Size and Forecast (US$ Bn), By End User, 2022 – 2032
      • Market Size and Forecast (US$ Bn), By Country, 2022 – 2032
        • Brazil
        • Mexico
        • Rest of Latin America
    • Middle East & Africa
      • Market Size and Forecast (US$ Bn), By Product Type, 2022 – 2032
      • Market Size and Forecast (US$ Bn), By End User, 2022 – 2032
      • Market Size and Forecast (US$ Bn), By Country, 2022 – 2032
        • GCC
        • Israel
        • South Africa
        • Rest of Middle East
  8. Competitive Landscape
    • Heat Map Analysis
    • Market Presence and Specificity Analysis
  9. Company Profiles
  • Medtronic
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Boston Scientific Corporation
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Biotronik
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • LivaNova plc
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Abbott
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Microport
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Koninklijke Philips N.V
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Nihon Kohden Corporation
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Progetti Srl
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Fukuda Denshi Co., Ltd
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Getinge
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • ZOLL Medical Corporation
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  1. The Last Word
    • Future Impact
    • About Us
    • Contact

FAQs

Implantable Cardioverter Defibrillator Market is segmented into basis of on product type, end user, and region.

Increase in cardiovascular diseases, increasing prevalence of cardiovascular diseases, increasing geriatric population, increasing applicability of implantable cardioverter defibrillators are the reasons driving the market growth.

North America is expected to be the largest implantable cardioverter defibrillator market during the forecast period, owing to increasing prevalence of heart disease, high adoption rate of cardiac implantable electronic devices, presence of a well-established healthcare sector, and the US being the largest growing region due to growing elderly population in the region.

Key players operating in the Implantable Cardioverter Defibrillator Market includes Medtronic, Boston Scientific Corporation, Biotronik, LivaNova Plc, Abbott, Microport, Koninklijke Philips N.V., Nihon Kohden Corporation, Progetti Srl, Fukuda Denshi Co., Ltd, Getinge, ZOLL Medical Corporation.